Patient experience specialist Medfusion acquires NexSched
Patient experience technology vendor Medfusion Inc. announced at HIMSS17 that it has acquired NexSched LLC, a company that specializes in patient self-scheduling systems. The acquisition is expected to close by the end of the month.
The addition of NexSched’s technology supports Medfusion’s overall goal of empowering patients to take control of their care in the era of healthcare consumerism, Medfusion said. 77 percent of patients think that the ability to book, change or cancel appointments online is vitally important to their healthcare experience, a recent Accenture study found. Medfusion’s acquisition of NexSched directly addresses this consumer demand for greater control by giving patients 24/7 access to schedule their own appointments, the company said.
“With NexSched, we are meeting the patient demand for an improved healthcare experience, and arming practices with the technology they need to be successful in a consumer-driven market,” said Kimberly Labow, CEO of Medfusion. “By combining the forces of our powerful patient-centered solutions, we are enabling the patient to self-schedule their appointment, pay their co-pay or outstanding balance, and access their medical records all from their mobile device. This acquisition is a strong strategic fit with Medfusion's core offerings and accelerates the growth of our Patient Experience platform.”
NexSched’s technology boosts practices’ organizational efficiency by decreasing call volume, lowering no-show numbers and increasing patient enrollment – resulting in significant cost savings, NexSched contended. The customizable software allows patients to fill doctors’ schedules by offering same-day and future appointments or group pre-booking of simple procedures, like annual flu shots, the company added. Filters ensure practices retain full control over scheduling and appointments.
This article is part of our ongoing coverage of HIMSS17. Visit Destination HIMSS17 for previews, reporting live from the show floor and after the conference.
